Janus kinase 2
Janus Kinase 2
Janus Kinase 2 (pronounced: JAY-nus KAY-skin TOO), often abbreviated as JAK2, is a non-receptor tyrosine kinase that plays a crucial role in signal transduction for various cytokines and growth factors.
Etymology
The term "Janus Kinase" is derived from the Roman god Janus, who is often depicted with two faces, symbolizing the dual nature of this kinase. The number "2" signifies its position in the family of Janus kinases, which includes JAK1, JAK2, JAK3, and TYK2.
Function
JAK2 is involved in the signaling pathways of various cytokines and growth factors, including erythropoietin and thrombopoietin. It is activated upon ligand binding to the receptor, leading to phosphorylation and activation of signal transducers and activators of transcription (STATs), which then translocate to the nucleus and regulate gene expression.
Clinical Significance
Mutations in the JAK2 gene are associated with several hematological disorders, including polycythemia vera, essential thrombocythemia, and myelofibrosis. The most common mutation, JAK2 V617F, results in constitutive activation of the kinase, leading to uncontrolled cell proliferation.
Related Terms
- Janus Kinase 1 (JAK1)
- Janus Kinase 3 (JAK3)
- Tyrosine Kinase 2 (TYK2)
- Cytokines
- Growth Factors
- Signal Transducers and Activators of Transcription (STATs)
- Polycythemia Vera
- Essential Thrombocythemia
- Myelofibrosis
External links
- Medical encyclopedia article on Janus kinase 2
- Wikipedia's article - Janus kinase 2
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski